• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL DELTAPAQ CERE 2MMX8CM; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL DELTAPAQ CERE 2MMX8CM; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Model Number CDF100208-30
Device Problem Separation Failure (2547)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/06/2022
Event Type  malfunction  
Event Description
As reported by the field, during a coil embolization, the doctor filled the aneurysm with deltapaq cere 2mmx8cm coil (cdf10020830, lot unknown) and pressed the detachment box to detach it, but the coil could not be detached.The physician retracted the coil and to a new competitor¿s coil to complete the surgery.There was no patient injury reported.
 
Manufacturer Narrative
Product complaint #
=
> (b)(4).Procode: krd/hcg.The device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).One picture was attached to the complaint file.Based on the visual analysis, one section of the device could be noted, and no damages can be seen.The label was also shown in the picture.Due to the picture, it cannot be determined if the detachment process was initiated since the resistance heat (rh) was not able to be evaluated.No other damages can be seen.A manufacturing record evaluation was performed, and no non-conformances related to the reported complaint condition were identified.The customer complaint was not able to be confirmed.This investigation was performed based only on the picture provided.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Manufacturer Narrative
Product complaint #(b)(4).Section b5: additional information received indicated that pre-deployment electrical testing was performed.The same dcb nor the same cable were used with subsequent coils.The coil was still attached to the coil delivery system when removed from the patient.The coil did not become stretched or damaged.The target vessel/site was the left middle cerebral artery.The procedure was not delayed due to the event.The concomitant devices functioned as expected.Complaint conclusion: as reported by the field, during a coil embolization, the doctor filled the aneurysm with deltapaq cere 2mmx8cm coil (cdf10020830, s14638) and pressed the detachment box to detach it, but the coil could not be detached.The physician retracted the coil to a new competitor¿s coil to complete the surgery.There was no patient injury reported.Additional information received indicated that pre-deployment electrical testing was performed.The same dcb nor the same cable were used with subsequent coils.The coil was still attached to the coil delivery system when removed from the patient.The coil did not become stretched or damaged.The target vessel/site was the left middle cerebral artery.The procedure was not delayed due to the event.The concomitant devices functioned as expected.Picture provided by customer shows only one section of the device, however, the resistance heating (rh) section was not observed on the picture provided.A non-sterile deltapaq cere 2mmx8cm was received contained in the decontamination pouch.Upon receiving the device, a visual inspection was performed, and the device was found in good normal conditions (i.E., no kinks, peeling or broken condition were observed).The device was inspected under microscopic magnification, and it was found that the embolic coil is not attached to the rest of the device and it was not returned for evaluation with the rest of the device, also, the resistance heating (rh) was observed overheated, the overheated condition noted on the rh suggests that the detachment cycle was performed several times.The loss condition of the embolic coil is suspected to have occurred sometime during the post-operative handling or decontamination of the microcoil as according to the information provided by the customer the coil was still attached to the coil delivery system when removed from the patient.However, this cannot be conclusively determined.Failure to detach is a known potential issue associated with the use of this device.The instructions for use (ifu) contains several precautions related to this issue and includes instructions for troubleshooting the situation should it be encountered during use.Based on the conditions in which the device was received and the information provided by the customer, the customer¿s complaint regarding a failure to detach was confirmed.A manufacturing record evaluation was performed, and no non-conformances related to the reported complaint condition were identified.It should be noted that failure could be caused by multiple factors.The instructions for use (ifu) do contain the following recommendations: verify that the microcoil delivery system is fully connected, and no faults are indicated on the dcb.If a fault exists, reseat all connections between the dpu, the dcb, and the connecting cable.If a fault still persists, replace the connecting cable.If this does not correct the error, replace the dcb.If the microcoil delivery system still continues to have a fault, retrieve the microcoil, re sheathing the microcoil system, and replace it with a new microcoil system.Assignment of root cause for the event remains speculative and inconclusive, based on the limited information provided and the evidence presented by the returned device; however, it is possible that clinical and procedural factors, including device manipulation and device interaction, may have contributed to the reported failures and damages on the returned system.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAPAQ CERE 2MMX8CM
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN & SHURTLEFF, INC. (FREMONT)
47709 fremont blvd
fremont CA 94538
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14652616
MDR Text Key301122568
Report Number3008114965-2022-00411
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00878528007104
UDI-Public00878528007104
Combination Product (y/n)N
PMA/PMN Number
K080437
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2022
Device Model NumberCDF100208-30
Device Catalogue NumberCDF10020830
Device Lot NumberS14638
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/18/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/26/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK DETACHMENT CONTROL BOX
-
-